Swedish Orphan Biovitrum
MA - WalthamBiotechnology
Focus: Swedish Orphan Biovitrum is a publicly traded specialty biotech headquartered in Waltham, MA, focused on rare diseases, oncology, immunology, and hematology through biologic therapies. The company operates a portfolio of established and pipeline biologics with significant exposure to rare disease markets.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
91-2 this month
Stable — net -2 jobs in 30d
28 added, 30 removed. Backfill posture.
Should You Work at Swedish Orphan Biovitrum?
AI assessmentViable option for rare disease specialists and commercial professionals, but career longevity depends on successful pipeline advancement given critical KINERET patent cliff risk.
Why Work Here
- Rare disease focus offers deep clinical expertise and smaller, highly engaged patient populations — ideal for clinical, medical affairs, and translational roles
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$28M Part DDeclining
LOE Approaching
Revenue anchor representing 99% of company income, but patent expiration imminent; represents existential risk to current business model.
Help build intelligence for Swedish Orphan Biovitrum
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.